Genomics Guide Treatment Escalation DeEscalation in HR Breast Cancer

Genomics Guide Treatment Escalation, De-Escalation in HR+ Breast Cancer

Stephanie L. Graff, MD, discusses data surrounding escalation and de-escalation in patients with early-stage, hormone receptor–positive breast cancer.

Original Article: Genomics Guide Treatment Escalation, De-Escalation in HR+ Breast Cancer

More From BioPortfolio on "Genomics Guide Treatment Escalation, De-Escalation in HR+ Breast Cancer"